Sun Pharmaceutical
SUNPHARMA.NS
#517
Rank
โ‚น4.645 T
Marketcap
โ‚น1,936
Share price
-1.30%
Change (1 day)
14.24%
Change (1 year)

Revenue for Sun Pharmaceutical (SUNPHARMA.NS)

Revenue in 2026 (TTM): โ‚น566.30 Billion

According to Sun Pharmaceutical 's latest financial reports the company's current revenue (TTM ) is โ‚น616.29 Billion. In 2024 the company made a revenue of โ‚น510.39 Billion an increase over the revenue in the year 2023 that were of โ‚น466.70 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Sun Pharmaceutical from 2012 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚น566.30 B
2024 โ‚น510.39 B9.36%
2023 โ‚น466.70 B11.28%
2022 โ‚น419.39 B11.92%
2021 โ‚น374.71 B14.08%
2020 โ‚น328.47 B4.97%
2019 โ‚น312.91 B10.36%
2018 โ‚น283.53 B8.3%
2017 โ‚น261.80 B-15.15%
2016 โ‚น308.55 B16.12%
2015 โ‚น265.72 B5.35%
2014 โ‚น252.21 B67.72%
2013 โ‚น150.37 B43.31%
2012 โ‚น104.93 B